Among the signature genes we researched, HSPA4, FABP6, S100A10, CACYBP, SHC1 and HDAC1 were associated with a higher tumor grade (Figure 8A–8F), CACYBP was linked with a higher clinical stage as well as T stage (Figure 8G and 8H). The gene discussed is SHC1; the disease is neoplasm.